Two weeks after going public, Jacksonville biopharmaceutical company Cadrenal Therapeutics Inc. celebrated its new listing by ringing the closing bell at the Nasdaq stock exchange.
Cadrenal is focused on developing tecarfarin, a drug that will be aims to prevent blood clots in people who have end-stage renal disease and atrial fibrillation, or irregular heart beats. The FDA considers tecarfarin an orphan drug, which means the company qualifies for certain tax credits and other incentives to help bring it to market. It has also received fast track designation, which speeds up the process of getting a drug approved.
เราได้สรุปข่าวนี้มาให้อ่านอย่างรวดเร็ว หากสนใจข่าว สามารถอ่านฉบับเต็มได้ที่นี่ อ่านเพิ่มเติม:
ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว
Similar News:คุณยังสามารถอ่านข่าวที่คล้ายกันนี้ซึ่งเรารวบรวมจากแหล่งข่าวอื่น ๆ ได้
Expansion Jacksonville soccer team selects former JU coach for leadership position - Jacksonville Business JournalMauricio Ruiz joined the organization in a business development role where he will also 'advise and support' operations.
แหล่ง: JaxBizJournal - 🏆 599. / 51 อ่านเพิ่มเติม »
Jacksonville Airport construction - Jacksonville Business JournalJacksonville International has many changes in store to make travel more efficient for every passenger. See where all of the major projects stand today.
แหล่ง: JaxBizJournal - 🏆 599. / 51 อ่านเพิ่มเติม »
Expansion Jacksonville soccer team selects former JU coach for leadership position - Jacksonville Business JournalMauricio Ruiz joined the organization in a business development role where he will also 'advise and support' operations.
แหล่ง: JaxBizJournal - 🏆 599. / 51 อ่านเพิ่มเติม »
Concessions offered to lure office tenants are eating away at landlords' income - Jacksonville Business JournalA growing spread between starting and effective rents illustrates how office landlords — even among coveted Class A buildings — are seeing their rental income eroded as the office market remains squarely in favor of tenants.
แหล่ง: JaxBizJournal - 🏆 599. / 51 อ่านเพิ่มเติม »